EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹21 Cr | ₹19 Cr | ₹9.49 Cr | ₹8.03 Cr | ₹0.08 Cr |
What is the latest Capital Work in Progress ratio of EVEREST ORGANICS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹9.49 Cr |
| Mar2022 | ₹8.03 Cr |
| Mar2021 | ₹0.08 Cr |
How is Capital Work in Progress of EVEREST ORGANICS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 10.46 | |
| Mar2024 | ₹19 Cr | 103.86 | |
| Mar2023 | ₹9.49 Cr | 18.18 | |
| Mar2022 | ₹8.03 Cr | 10,606.67 | |
| Mar2021 | ₹0.08 Cr | - | |
Compare Capital Work in Progress of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹302.7 Cr | 14% | 21.5% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 14% |
21.5% |
-12.8% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses